Oslo, February 13, 2024 - Observe Medical ("the Company" or "Observe Medical")
has received first orders for delivery of UnoMeterT 500 products from our
distributor in Ireland, Armstrong Medical.

We are set to dispatch 2,800 units of the UnoMeterT 500 this week, with an
additional 2,500 units scheduled for shipment by the end of February. The
shipments are being facilitated via C&P Medical, our distributor based in the
UK. This initial order places us well within the Urinemeter market in Ireland,
which has an annual potential of approximately 15,000 units.

Armstrong Medical will exclusively service all demands for the UnoMeterT 500 in
Ireland.

Jørgen Mann, Chief Commercial Officer at Observe Medical, remarked, "We are
pleased to secure our first UnoMeter orders in the Irish hospital market. The
partnership with Armstrong Medical is instrumental in servicing the growing
demand for our products in Ireland and we are looking forward to further
strengthening our presence in this market going forward".

For further information, please contact:

Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com

Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com

About Armstrong Medical

Armstrong Medical was formed in 1984 by John Armstrong MBE, initially as a
medical device distributor, later developing to become a specialist manufacturer
of acute respiratory care consumables, exporting to more than 60 countries.

Based in Coleraine, Northern Ireland, their 90,000 sq ft facility includes
design, prototype, mould making, injection moulding extrusion and cleanroom
assembly.

Each year, their products are used on an estimated 7.5 million patients for
anaesthesia, and the resuscitation and respiratory support of 65,000 babies and
35,000 adults.

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available at www.observemedical.com.